GREENLAND MINES LTD Shareholders' Equity
GREENLAND MINES LTD (GRML) had Shareholders' Equity of $57.90 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-17
- 2026-06-30: Stockholders' Equity Attributable to Parent $57.90M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $51.47M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.46M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.93M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $57.90M 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $51.47M 10-Q · filed 2026-08-17 | |
| 2025-12-31 | $9.46M 10-Q · filed 2026-08-17 | |
| 2025-09-30 | $9.93M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $10.65M 10-Q · filed 2026-08-17 | |
| 2025-03-31 | $638.71K 10-Q · filed 2026-08-17 | |
| 2024-12-31 | $1.19M 10-Q · filed 2026-08-17 | |
| 2024-09-30 | $1.46M 10-Q · filed 2025-11-13 | $1.46M 10-Q · filed 2024-11-19 |
| 2024-06-30 | -$1.55M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $360.01K 10-Q · filed 2025-11-13 | -$7.73M 10-Q · filed 2024-05-23 |
| 2023-12-31 | -$442.70K 10-K/A · filed 2026-08-14 | -$7.35M 10-K · filed 2024-04-17 |
| 2023-09-30 | $698.19K 10-Q · filed 2024-11-19 | -$6.44M 10-Q · filed 2023-11-17 |
| 2023-06-30 | -$6.05M 10-Q · filed 2023-11-17 | |
| 2023-03-31 | -$4.88M 10-Q · filed 2024-05-23 | |
| 2022-12-31 | -$4.04M 10-Q · filed 2024-05-23 | |
| 2022-09-30 | -$4.01M 10-Q · filed 2023-11-17 | |
| 2022-06-30 | -$4.28M 10-Q · filed 2023-11-17 | |
| 2022-03-31 | $16.43K 10-Q · filed 2023-11-17 | |
| 2021-12-31 | -$3.56K 10-K · filed 2024-04-17 | |
| 2021-09-30 | -$3.53K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$3.51K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$3.51K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |